Navigation Links
InterCure and High Tech Health Announce RESPeRATE Launch into Pharmacy Market in Australia
Date:10/1/2007

Country's Largest Distributors and Pharmacy Chains to Carry RESPeRATE

Hypertension Treatment Device

NEW YORK and MAROOCHYDORE, Australia, Oct. 1 /PRNewswire/ -- InterCure, Ltd. (TASE: INCR), today announced that its RESPeRATE(R) hypertension treatment device, clinically-proven in 10 published studies to significantly lower blood pressure, will launch into retail distribution in Australia through its local marketing and distribution partner, High Tech Health (HTH). RESPeRATE will be distributed through Australia's three largest pharmacy wholesalers into leading pharmacy chains nationwide, including Chemmart, Terry White and Think Pharmacy. This retail distribution partnership marks another key step in RESPeRATE's channel evolution, as it expands from a direct-to- consumer model to more traditional pharmacy channels globally.

High Tech Health will initially introduce RESPeRATE into 300 retail pharmacy locations in early Q4. HTH will leverage its network of merchandising specialists to ensure that each pharmacy staff person is well-trained in the use and benefits of RESPeRATE, to establish merchandising programs at the store level and to hold community patient education sessions on hypertension management and the use of RESPeRATE. HTH currently serves about 1,000 of the 5,000 pharmacies in Australia.

"This is great news for the millions of hypertension sufferers in Australia who seek a new option to help control their condition," said Erez Gavish, president and CEO of InterCure. "The vast majority of our prospective customers tell us that they would prefer to buy RESPeRATE at their local pharmacy. Our move into the Australian pharmacy channel will allow consumers to buy at their preferred retailer for health products, while building a strong retail presence for InterCure. This marks another key step in the Company's broad strategy of adding pharmacy distribution to our direct sales platform."

Almost one billion people worldwide have high blood pressure, including nearly one in three Australians. According to the National Heart Foundation of Australia, hypertension is the most frequently managed problem in general physician practices. Traditional treatment methods of diet, exercise and medication are often unable to help patients reach their lower blood pressure goals. Left untreated, high blood pressure may lead to heart attack, stroke and kidney or heart failure.

"RESPeRATE is a perfect fit within our health solutions portfolio of brands. It complements well our existing pharmacy product offerings, and we look forward to bringing our point of presence expertise to this innovative solution for hypertensives in Australia. Our focus on a high-touch retail approach, with a particular emphasis on pharmacy staff will surely establish RESPeRATE well with our pharmacy partners and their trusting customers," said Sam Penny, president of High Tech Health.

"We are excited to have the opportunity to introduce a clinically-proven, non-drug alternative to our customers to assist in the treatment of high blood pressure," said Sharon Bell of Think Pharmacy.

About RESPeRATE

RESPeRATE(R) is FDA-cleared for over-the-counter sale and is the only medical device on the market clinically-proven to lower blood pressure through paced breathing therapy. The device uses the body's natural tendency to follow external rhythms, interactively guiding the user to effortlessly reduce their breathing rate to a "therapeutic zone" of less than 10 breaths per minute. The breathing exercises with RESPeRATE relax the constricted muscles surrounding the small blood vessels, allowing the blood to flow more freely and yielding a significant and lasting reduction of blood pressure within weeks.

About InterCure, Ltd.

InterCure, a medical device company publicly traded on the Tel Aviv Stock Exchange (TASE: INCR) has become a leader in the growing Personal Therapeutic Device category. Its broadly patented "device-guided breathing" technology platform enables a systematic reduction in sympathetic outflow of the autonomic nervous system. InterCure is successfully selling the world's first hypertension treatment device, RESPeRATE(R), with more than 75,000 units sold. With multiple published clinical studies, regulatory clearance in most key international markets (including FDA over-the-counter ("OTC") clearance in the U.S., the European CE mark and the Chinese SDA among others) and a renowned scientific advisory board, RESPeRATE is rapidly becoming a part of the standard of care for the treatment of hypertension. (http://www.intercure.com)

About High Tech Health

High Tech Health is a privately owned company committed to improving the health of consumers through innovative medical devices and better education about drug-free alternatives. HTH is now Australia's leading supplier of OTC medical devices supplying almost 1,000 pharmacies as well as circulating its much acclaimed newsletter to nearly 50,000 subscribers.

HTH launched in the United Kingdom with New Zealand being established in early 2007 to follow the same commitment of its Australian operations; to create a range of medical devices that perform, provide results and are backed by clinical evidence. (http://www.hightechhealth.com.au)

Forward-Looking Statements

This news release may contain forward-looking statements that are based on the Company's current beliefs and assumptions and on information currently available to its management. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. As a result of these risks, uncertainties and other factors, readers are cautioned not to place undue reliance on any forward-looking statements included in this press release. These forward- looking statements represent beliefs and assumptions only as of the date of this news release, and the Company assumes no obligation to update these forward-looking statements publicly, even if new information becomes available in the future.

Contacts:

Jane Hauser

Schwartz Communications

781-684-0770

intercure@schwartz-pr.com

Brian Packard

InterCure, Inc.

646-652-5800

bpackard@intercure.com

Gaby Roach

High Tech Health

+1-800-505-108/+61-7-5443-9767

gaby@hightechhealth.com.au


'/>"/>
SOURCE InterCure, Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Poor health care in Russia maybe causing Decline in its Population
2. Startling Expose – Physicians Often Have No Regular Source Of Health Car
3. Debate Rages over firing of HIV infected health care workers
4. Want a Healthy brew? Have some Tea!
5. Patient’s perception of health status helps in better recover
6. Antioxidants protect health tissue in people undergoing radiation therapy.
7. Sexual abuse affect health for a lifetime
8. Smoking a greater risk than HIV? Yes say health experts!!!!
9. Healthcare sector is now a multi billion-dollar industry in India
10. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
11. How much can exercise improve health?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... Castle Farms, the ... Military Wedding Giveaway, with the winning couple announced on Feb. 14, 2017, on ... donated from local vendors: A Matter of Taste, Ryan Rousseau Enterprises, A Touch ...
(Date:2/23/2017)... ... February 23, 2017 , ... On February ... a letter to withdraw previous guidance issued by the Obama Administration ... guidance issued in May 2016 by the Obama Administration came in response to ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Lymphoma ... innovative lymphoma research and serving the lymphoma community through a comprehensive series of ... Gorce Country Club in Miami Beach to host its Swirl: Miami Wine Tasting ...
(Date:2/23/2017)... Chapel Hill, NC (PRWEB) , ... February 23, 2017 , ... ... the Platinum Sponsor for ACPA’s 74th Annual Meeting. KLS is a longtime supporter ... in 2017 as an exhibitor and Platinum Sponsor," said Dr. Bob Havlik, 2017 ACPA ...
(Date:2/23/2017)... ... 2017 , ... Hamlin Dental Group and Dr. Hamid Reza, dentist in ... the month of February, patients who visit Hamlin Dental Group will receive a ticket ... two at the Cheesecake Factory. , Tickets are available for routine dental visits ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... ITL Limited, ( ASX : ITD ), une société de ... excellents résultats semestriels clos le 31 décembre 2016 par ... « Résultats et mise à jour sur la croissance biomédicale ... Faits marquants Bénéfice ... hausse de 104 %) Bénéfice par action ...
(Date:2/24/2017)... Medivir AB (Nasdaq Stockholm: MVIR) ... Board of Directors that will be submitted to the ... representatives of the company,s three largest shareholders at the ... accepted a seat on the Nomination Committee, and the ... Nomination Committee was as follows:  ...
(Date:2/23/2017)... 2017  Genesis Healthcare Services has merged with Hospice ... by Bill Monast , President and CEO of ... Nathan Feltman , executives with Home Health Depot, Inc., ... This acquisition helps Hospice Cloud maintain its ... durable medical equipment (DME) solutions for the hospice industry. ...
Breaking Medicine Technology: